Oncostatin M induces RIG‐I and MDA5 expression and enhances the double‐stranded RNA response in fibroblasts

Abstract Interleukin (IL)‐6‐type cytokines have no direct antiviral activity; nevertheless, they display immune‐modulatory functions. Oncostatin M (OSM), a member of the IL‐6 family, has recently been shown to induce a distinct number of classical interferon stimulated genes (ISG). Most of them are involved in antigen processing and presentation. However, induction of retinoic acid‐inducible gene (RIG)‐I‐like receptors (RLR) has not been investigated. Here we report that OSM has the capability to induce the expression of the DExD/H‐Box RNA helicases RIG‐I and melanoma differentiation antigen 5 (MDA5) as well as of the transcription factors interferon regulatory factor (IRF)1, IRF7 and IRF9 in primary fibroblasts. Induction of the helicases depends on tyrosine as well as serine phosphorylation of STAT1. Moreover, we could show that the OSM‐induced STAT1 phosphorylation is predominantly counter‐regulated by a strong STAT3‐dependent SOCS3 induction, as Stat3 as well as Socs3 knock‐down results in an enhanced and prolonged helicase and IRF expression. Other factors involved in regulation of STAT1 or IRF1 activity, like protein tyrosine phosphatase, non‐receptor type 2 (PTPN2), promyelocytic leukaemia protein (PML) or small ubiquitin‐related modifier 1 (SUMO1), play a minor role in OSM‐mediated induction of RLR. Remarkably, OSM and interferon‐γ (IFN‐γ) synergize to mediate transcription of RLR and pre‐treatment of fibroblasts with OSM fosters the type I interferon production in response to a subsequent encounter with double‐stranded RNA. Together, these findings suggest that the OSM‐induced JAK/STAT1 signalling is implicated in virus protection of non‐professional immune cells and may cooperate with interferons to enhance RLR expression in these cells.


Introduction
Activation of pattern recognition receptors (PRR) is the first line of defence against infection by pathogens. PRR can be classified into four main families: the Toll-like receptors (TLR), the C-type lectin receptors (CTL), the retinoic acid-inducible gene (RIG)-I-like receptors (RLR) and nucleotide binding leucine-rich repeat (NLR) containing receptors, also known as NOD-like receptors. The first two are membrane-bound receptors, whereas the latter two are localized in the cytoplasm.
Recently OSM, another member of the IL-6-type cytokine family, was shown to induce a distinct number of classical interferon target genes (ISG) [18]. In combination with type I IFNs, OSM synergized in the inhibition of HCV and HAV infection in hepatoma cells by an enhanced expression of a subset of ISG as well as induction of immune stimulatory molecules like IL-7 and IL-15R, which are implicated in T-cell effector functions [19][20][21]. OSM is produced by activated monocytes and macrophages [22,23], but can also be released by neutrophils and dendritic cells upon stimulation with LPS or granulocyte/macrophage-colony stimulating factor (GM-CSF) [20,[24][25][26][27][28]. In the human system, OSM can bind to two receptor complexes. The type I receptor complex consists of the common signal transducer glycoprotein 130 (gp130) and the leukaemia inhibitory factor receptor (LIFRb), and the type II receptor complex consists of gp130 and the specific OSM receptor (OSMRb) [29][30][31][32]. As tissue-resident cells, like fibroblasts, express both LIFRb and OSMRb, they are potential target cells of OSM. Fibroblasts are found in all tissues and referred to as sentinel cells of the connective tissue. Although fibroblasts are non-professional immune cells, they play an important role in the innate and adaptive immunity, particularly in the early innate immune response due to their ability to produce high levels of IFN [33].
In the current study, we examined the expression of ISG upon stimulation with OSM and found that RLR as well as several IRF were strongly induced in primary human dermal fibroblasts (HDF). The expression of the pattern recognition receptors of the RLR subtype RIG-I and MDA5 as well as of the interferon-regulated transcription factors IRF1, IRF7 and IRF9 was rapidly induced by the OSM-activated STAT1 within these cells. Moreover, we provide evidence that the STAT1 phosphorylation and ISG expression in HDF is predominantly counter-regulated by a STAT3-dependent SOCS3 expression, as knock-down of Stat3 or Socs3 prolonged the OSM-induced STAT1 signalling and therefore also helicase and IRF expression. Previous studies suggested that OSM and IFN synergize in induction of antiviral defence mechanisms in hepatocytes. Here, we show that the OSMinduced JAK/STAT1 signalling sensitizes HDF to the encounter of double-stranded RNA and supports IFN-c signalling to increase the RIG-I and MDA5 expression.

Small interfering RNA (siRNA) transfection
Human LIFR, STAT1, STAT3, SOCS3, PML, PTPN2 and SUMO1 siRNA (ON-TARGET plus SMARTpool) were purchased from Dharmacon (Thermo Fisher Scientific Inc.) and non-silencing control siRNA (AllStars negative Control siRNA) from Qiagen (Hilden, Germany). HDF were transfected 4 hrs after plating (0.4 9 10 5 cells per well in 12-well plates) with 33 nM siRNA using Lipofectamine RNAiMax (Invitrogen) according to the manufacturer's instructions. At day two post-transfection, cells were stimulated and lysed for protein detection by Western Blot analysis or RNA extraction for quantitative real-time RT-PCR.
Quantitative and semi-quantitative RT-PCR RNA was isolated using the RNeasy kit (Qiagen) according to the manufacturer's instructions. For quantitative RT-PCR, up to 1 lg total RNA was used for cDNA synthesis using the Transcriptor First-Strand cDNA Synthesis Kit from Roche Diagnostics (Mannheim, Germany). Quantitative real-time RT-PCR was performed using the FastStart Universal SYBR Green Master (Rox) Kit (Roche Diagnostics) according to manufacturer's instructions with specific primer pairs designed using the Universal ProbeLibrary Software (Roche) ( Table 1). For each target mRNA analysed, 5 ll of FastStart Universal SYBR Green master mix, 400 nM of each primer pair, 2.2 ll nuclease-free water and 2 ll of cDNA were mixed in 384-well plates in duplicates using a robot (Qiagility; Qiagen), and qPCR was carried out on an ABI PRISM 7900HT (Applied Biosystems, Darmstadt, Germany): initial activation 10 min. at 95°C, 40  For semiquantitative RT-PCR, 1 lg total RNA was reverse-transcribed using the One-Step RT-PCR kit (Qiagen) and the following PCR conditions: initial activation 15 min. at 95°C, 35 cycles denaturation, 40 sec. 94°C, hybridization 30 sec. 56°C, elongation 30 sec. 72°C and final elongation 10 min. 72°C. PCR products were separated on 1% agarose gels and stained with ethidium bromide.

ELISA
Subconfluent cultures (70-80%) were left untreated or pre-incubated for 2 hrs with 20 ng/ml OSM before stimulation with 5 or 100 lg/ml poly I:C for 2 hrs. Supernatants were collected, concentrated and analysed by ELISA. The human IFN-b ELISA kit was purchased from PBL Assay Science, Piscataway, NJ, USA (# 41410) and used according to the manufacturer's protocol.

Statistical analysis
All data are given as mean + S.E.M. (standard error of means) using an unpaired, two-tailed Student's t-test or Mann-Whitney U-test, unless indicated differently in the respective figure legend. A value of P < 0.05 (*), P ≤ 0.01 (**) or P ≤ 0.001 (***) was considered statistically significant.

Results
RIG-I and MDA5 are early target genes of OSM in primary human fibroblasts A preliminary microarray-based screening experiment performed with OSM-treated human dermal fibroblasts (HDF, not shown) indicated that OSM might induce the expression of a panel of ISG, including the RLR RIG-I (gene: DDX58) and MDA5 (gene: IFIH1), as well as the transcription factor IRF1. To confirm these results, we stimulated HDF for different time periods with OSM and examined mRNA and protein expression by qRT-PCR and Western Blot analysis. We found a strong and statistically significant increase in IRF1, DDX58 and IFIH1 mRNA levels as early response to OSM stimulation ( Fig. 1A-C). The expression of DDX58 and IFIH1 mRNA peaked after 2-3 hrs of stimulation and declined thereafter, while the increase in IRF1 mRNA expression preceded the helicase induction with a maximum after 1 hr of OSM stimulation. Similar results were obtained on protein level. IRF1 protein was present up to 3 hrs; RIG-I and MDA5 protein expression peaked after 5 hrs stimulation and slowly returned to basal levels thereafter. Interestingly, besides IRF1, two other IRF essential for the antiviral response, namely IRF7 and IRF9, were found to be OSM target genes ( Fig. 1D and E). Similar to DDX58 and IFIH1, enhanced transcription of IRF7 and IRF9 mRNA in response to OSM was detectable with a maximum at 3 hrs of stimulation.
Taken together, our data demonstrate that OSM induces a transient expression of ISG in primary fibroblasts, characterized by an early and strong IRF1 response followed by the induction of RIG-I, MDA5, IRF7 and IRF9.

Expression of the LIFR is dispensable for the OSM-induced expression of ISG
Human fibroblasts express gp130, LIFR and OSMR. Therefore, they are not only responsive to OSM, but additionally to IL-6 trans-signalling [37] and LIF. To investigate whether the induction of RLR expression is a more general response of human fibroblasts to IL-6-type cytokines, we stimulated HDF either with LIF or with IL-6 in combination with its soluble a-receptor (sIL-6Ra) for 5 hrs and analysed the protein expression of RIG-I and MDA5 ( Fig. 2A). While OSM induced the expression of RIG-I and MDA5, neither LIF nor IL-6/sIL-6R stimulation enhanced RIG-I and MDA5 protein expression in HDF ( Fig. 2A). Accordingly, we hypothesized that the OSM-mediated expression of RLR is mediated by the type II OSM receptor complex (gp130/OSMR) and independent of LIFR expression. For this reason, we transfected HDF with siRNA to LIFR and analysed the OSM-induced DDX58, IFIH1 and IRF1 mRNA expression by qRT-PCR. Efficient knock-down of the LIFR, shown by a complete loss of the LIFR mRNA expression (Fig. 2E), did not significantly influence the OSM-induced helicase and IRF1 expression ( Fig. 2B-D). Therefore, despite the fact that human OSM has equal affinity for both human LIFR and human OSMR, our data suggest that signalling through OSMR is sufficient to induce RIG-I, MDA5 and IRF expression in HDF. However, a minor contribution of the type I receptor complex cannot be excluded.

Helicase expression depends on STAT1 tyrosine and serine phosphorylation
To get a hint for the mechanism of OSM-induced RLR expression, we compared the tyrosine and serine STAT1 phosphorylation upon stimulation with OSM or IFN-c, a known inducer of RIG-I [8,9,38,39]. As expected, OSM and IFN-c induced a fast and strong tyrosine STAT1 phosphorylation (5 min.) followed by a slightly delayed serine STAT1 phosphorylation (15 min., Fig. 3A). While the IFN-c-induced tyrosine and serine STAT1 phosphorylation was present up to 24 hrs (Fig. 3B), particularly the OSM-induced STAT1 serine phosphorylation was more transient (Fig. 3A and B). Similarly, IRF1 protein expression peaked in response to OSM between 1 hr and 3 hrs after stimulation, while a clear increase in IRF1 protein was still detectable after 24 hrs of IFN-c stimulation (Fig. 3B). The transient OSM-induced STAT1 phosphorylation correlated well with the transient increase in RIG-I, MDA5 and IRF1 expression (Fig. 1). To further investigate whether the helicase and IRF expression relies indeed on dual-phosphorylated STAT1, cultured fibroblasts were stimulated with OSM after pre-treatment with well-established pharmacological inhibitors against the p38 MAPK (SB202190) or MEK1 (U0126). Both kinases have been implicated in the serine phosphorylation of STAT1 [40,41].
As expected, none of the inhibitors prevented OSM-mediated STAT1 tyrosine phosphorylation (Fig. 3C, left, top panel). However, the presence of SB202190 prevented OSM-induced serine 727 phosphorylation of STAT1 (Fig. 3C, left, third panel). The analysis of MK2 and ERK1/2 phosphorylation (Fig. 3C, right) proved the specificity of the used inhibitors. Interestingly, despite an intact STAT1 tyrosine phosphorylation, the induction of RIG-I mRNA and protein expression in response to OSM treatment is dependent on the activity of p38, but not MEK1/2 (Fig. 3D). This strongly suggested that STAT1 serine phosphorylation is a prerequisite for the subsequent initiation of RLR gene expression.
To further strengthen the importance of STAT1 in the OSMinduced RIG-I, MDA5 and IRF expression, we used STAT1 SMART pool siRNA to specifically downregulate STAT1 expression in HDF. As shown in Figure 4A, STAT1 siRNA transfection strongly decreased STAT1 protein expression and thus prevented the OSM-induced tyrosine STAT1 phosphorylation and IRF1 protein expression in HDF. The comparison with control siRNA-treated cells revealed that transfection did not affect the OSM-induced tyrosine STAT3 phosphorylation, and thus, IRF1 protein expression depends on OSM-induced STAT1 signalling. Consequently, we also observed a significant reduction in IRF1 mRNA levels in STAT1 siRNA-transfected, OSM-stimulated HDF (Fig. 4B). The same result was obtained for DDX58, IFIH1, IRF7 and IRF9 (Fig. 4C-F) mRNA levels.
In conclusion, the OSM-mediated expression of RIG-I, MDA5 and IRF1/7/9 in human fibroblasts depends on STAT1 tyrosine and serine phosphorylation.

RNA interference-mediated abrogation of STAT3 expression prolongs OSM-induced STAT1 signalling and ISG expression
It was demonstrated that murine embryonic fibroblasts (MEF) from STAT3-deficient mice display an enhanced RIG-I and MDA5 expression upon viral infection [42] as well as an IFN-c-like response after stimulation with IL-6/sIL-6Ra [43]. Both, Wang et al. and Costa-Pereira et al. provide evidence that STAT3 acts as a negative regulator either of the type I IFN or IL-6 response, as viral infection and/or cytokine activation of STAT3-deficient MEF resulted in enhanced/prolonged STAT1 phosphorylation and ISG expression.
OSM represents probably the strongest STAT3 activator within the family of IL-6-type cytokines, and STAT3 tyrosine phosphorylation in response to OSM is detectable for at least 24 hrs after OSM stimulation of HDF [44]. Thus, we asked whether STAT3 was a key regulator of STAT1 signalling in OSM-stimulated fibroblasts. As shown in Figure 5A and B, transfection of HDF with siRNA to STAT3 resulted in a complete loss of STAT3 mRNA and protein expression as well as STAT3 tyrosine phosphorylation. On the other hand, a marked increase in the level of tyrosine-phosphorylated STAT1 was detectable after 5 hrs and 10 hrs of OSM stimulation in STAT3 siRNA-treated HDF (Fig. 5B). Additionally, levels of total STAT1 protein increased over time in OSM-stimulated, STAT3 siRNA-transfected HDF but not in control siRNAtransfected cells (Fig. 5B, 10 hrs stimulation).
To determine whether the increased OSM-induced STAT1 phosphorylation results in an altered induction of ISG expression, we analysed mRNA and protein expression of RIG-I, MDA5 and IRF1 in STAT3 knock-down and control cells. As shown in Figure 5C-F, abrogation of STAT3 expression resulted in an enhanced and significantly prolonged induction of DDX58, IFIH1 and IRF1 mRNA as well as RIG-

SOCS3-main regulator of the OSM-induced STAT signalling
One of the major factors limiting IL-6-type cytokine responses, including OSM, is the suppressor of cytokine signalling 3 (SOCS3) [45][46][47]. As a direct target gene of STAT3, SOCS3 is considered to act as feedback inhibitor that shuts down cytokine-induced signal transduction to prevent chronic activation of signalling pathways. Indeed, in STAT3 siRNA-transfected HDF, no induction of SOCS3 mRNA was detectable in response to OSM stimulation (Fig. 5G).
On the contrary, the STAT1-dependent target gene SOCS1 was induced more pronouncedly and for significantly longer periods of time in response to OSM in STAT3 siRNA-treated HDF (Fig. 5H). This corresponded nicely with the prolonged and enhanced STAT1 tyrosine phosphorylation in STAT3 siRNA-transfected HDF (Fig. 5B).
To investigate whether SOCS3 might indeed not only be involved in shutdown of OSM-mediated signalling, but rather in fine-tuning the OSM-mediated STAT signalling pathways, we next transfected cells with siRNA to SOCS3. As shown in Figure 6A, levels of OSM-induced SOCS3 mRNA were almost absent in cells treated with SOCS3 siRNA compared with control siRNA-transfected HDF. Consistent with the results obtained in HDF transfected with STAT3 siRNA, STAT1 tyrosine phosphorylation (Fig. 6G, top panel) and SOCS1 gene expression (Fig. 6B) were strongly increased in SOCS3 siRNA-transfected and OSM-stimulated HDF. This correlated with a prolonged induction of ISG gene expression. IRF1, DDX58 and IFIH1 mRNA (Fig. 6C-E) and protein (Fig. 6G) were significantly stronger and longer detectable after OSM treatment of HDF transfected with SOCS3 siRNA compared to control siRNA-transfected cells. Intriguingly, despite the absence of SOCS3, STAT3 mRNA levels (Fig. 6F) and STAT3 tyrosine phosphorylation (Fig. 6G, last panel) were only mildly enhanced in response to OSM. We therefore conclude that STAT3-mediated SOCS3 induction affects the OSM-induced STAT1 tyrosine and serine phosphorylation much more pronouncedly than the OSM-induced STAT3 activation. Thereby, the initially induced STAT1 activation is rapidly turned off preventing prolonged activation of ISG in response to OSM.
Recent publications implicated that a number of additional proteins modify the STAT1/IRF-dependent expression of RLR. These include the tyrosine phosphatase PTPN2 which has been shown to be involved in STAT1 dephosphorylation [48], the small ubiquitin-like modifier (SUMO) [49] and the promyelocytic leukaemia protein (PML) [50,51]. To investigate whether these factors interfere with OSM-mediated induction of IRF1, DDX58 or IFIH1, HDF were transiently transfected with siRNA targeting each of these factors and changes in mRNA induction were evaluated in comparison with control siRNA-transfected cells (Fig. S1-S3).
Despite efficient knock-down of all targets, the transience in OSM-mediated induction of ISG was unaffected. PTPN2 knockdown slightly prolonged IRF1 induction (Fig. S1), which, however, did not significantly affect RLR expression and SUMO1 knock-down showed a trend towards slightly enhanced DDX58 and IFIH1 mRNA levels after 3 hrs of OSM stimulation (Fig. S2). Taken together, in comparison with STAT1, STAT3 and SOCS3, TC-PTP and SUMO1 appear to play a minor role in OSMmediated expression of the analysed ISG, while PML is completely dispensable.

Pre-treatment with OSM enhances the IFN-c-induced RLR expression and sensitizes HDF to double-stranded RNA
To investigate whether OSM and IFN-c could indeed act together to increase the antiviral response in HDF, cells were pre-treated with

3093
OSM followed by stimulation with IFN-c. The induction of DDX58 as well as IFIH1 mRNA expression was significantly stronger using a combination of OSM and IFN-c ( Fig. 7A and B, left panels) which translated in a more pronounced RIG-I and MDA5 protein expression when both cytokines were present (right panels). This suggests that OSM-mediated signalling could cooperate with IFN-c to enhance the antiviral response.
A major task for the RNA helicases RIG-I and MDA5 is the detection of double-stranded RNA (dsRNA) in the cytoplasm of cells, which is indicative of a viral infection. As treatment of fibroblasts with OSM resulted in an enhanced expression of RLR, we postulated that cells should become more sensitive to the presence of dsRNA. A widely used model for mimicking viral dsRNA is stimulation of cells with poly I:C. We therefore incubated HDF with 5 or 100 lg/ml poly I:C, 20 ng/ ml OSM or pre-treated the cells with OSM for 2 hrs and subsequently stimulated with 5 lg/ml poly I:C. By itself, the lower concentration of poly I:C was insufficient to provoke a substantial expression and release of IFN-b (Fig. 7C, 2 nd column). However, pre-treatment of

Discussion
Initiation of the early immune response starts with the activation of pattern recognition receptors (PRRs), which bind to conserved molecular structures of pathogens known as pathogen-associated molecular patterns (PAMPs). As host infection occurs via multiple routes, PRR are found at various cellular membranes (TLRs, Cleptin receptors) as well as within the cytoplasm (RLR, NOD) [52,53]. RIG-I-like receptors (RLR) are cytoplasmic RNA helicases, which are expressed at low levels in resting cells, but their expression is strongly induced during viral infection by secretion of type I interferons [6,54] as well as proinflammatory cytokines including IFN-c, IL-1b and TNF [4,9,[11][12][13]38,39,55,56]. It has been demonstrated that RIG-I is constitutively expressed in cells of the connective tissue including fibroblasts, epithelial and endothelial cells [1][2][3][4][5]. Moreover, it has been shown that RIG-I-deficient MEF failed to generate IFN-b upon viral infection, while virus-infected dendritic cells from RIG-I À/À mice secrete large amounts of type I IFN [1], indicating that RIG-I plays an important role in non-professional immune cells.
In the current study, we demonstrate for the first time that the RLR RIG-I and MDA5 as well as the transcription factors IRF1, IRF7 and IRF9 are strongly but transiently induced by OSM in HDF, whereas neither IL-6 nor LIF augmented their expression. Interestingly, increased transcription was not observed in HepG2 hepatoma or U2OS osteosarcoma cells, which implicates that the response might be restricted to certain cell types. We provide evidence that the OSM-induced expression depends on STAT1 phosphorylation, as helicase and also IRF1/IRF7/IRF9 expression were significantly inhibited in STAT1-depleted cells. Of note, LPSmediated expression of RIG-I and MDA5 was shown to be dependent on STAT2 expression and type I IFN signalling [57]. However, we have no evidence that OSM leads to tyrosine phosphorylation of STAT2 and therefore exclude the involvement of STAT2 in OSM-mediated ISG expression. Due to the observation that single Tyr701 STAT1 phosphorylation was not sufficient to induce RIG-I expression, we suggest that the OSM-induced expression depends on the simultaneously induced tyrosine and serine STAT1 phosphorylation, known to be required for maximal transcriptional activity of STATs [58,59]. Apparently, OSMmediated serine phosphorylation of STAT1 is dependent on p38 MAPK activity. In fibroblasts, OSM induced a Ser727 phosphorylation of STAT1 that was comparable in strength to IFN-c, while no Ser727 phosphorylation was detectable in SB202190 pre-treated cells. The differential regulation/kinetics of IRF1 and DDX58/IFIH1 gene expression by OSM led us to assume that the IRF1 protein expression might be a prerequisite for induction of DDX58/IFIH1 expression. In support of this hypothesis, previous findings indicate that mutation of a putative STAT1 binding site within the RIG-I (DDX58) promoter region had no effect on promoter activity, while mutation or deletion of the IRF1 binding site markedly reduced the RIG-I promoter activity [60]. Additionally, a stronger promoter activity is observed in IRF1-overexpressing cells, whereas IRF1 depletion by siRNA completely inhibited RIG-I induction [60,61]. A comparable IRF1-dependent mechanism for MDA5 expression has not been demonstrated so far.
SOCS proteins are the key physiological regulators of the cytokine-induced JAK/STAT pathway. Here, we demonstrate that the STAT3-induced SOCS3 is crucial to control STAT1 signalling in OSM-treated HDF and therefore limits OSM-induced ISG expression. In the absence of STAT3 or SOCS3, OSM treatment induced an enhanced and prolonged STAT1 signalling and ISG expression similar to that observed in IL-6-treated STAT3 À/À MEF or SOCS3 À/ À macrophages [43,47,62]. Croker et al. [47] and Lang et al. [62] further provide evidence that although IL-6 induced both SOCS1 and SOCS3, IL-6 signalling is specifically controlled by induction of SOCS3, as SOCS1 deficiency did not affect IL-6-induced STAT1 or STAT3 phosphorylation. Given that OSM induced an increase in SOCS1 mRNA expression in siSTAT3-and siSOCS3-treated HDF, our data provide strong evidence that SOCS3 is a specific regulator of OSM signalling as well. Thereby, our data strengthen recent findings for a role of SOCS3 in the negative regulation of OSMmediated signalling carried out in other cell types [45,46,63]. Importantly, our findings emphasize that SOCS3 does not act as a general inhibitor of OSM-induced signalling, as STAT3 tyrosine phosphorylation was not as strongly affected by SOCS3 knockdown compared to STAT1 phosphorylation. This indicates that SOCS3 action is essential to shape and specify the OSM signalling in a variety of cells types/tissues, particularly by modulating the ratio of STAT1 to STAT3 activation. This concept of opposing effects of STAT1 and STAT3 has been recognized in other cellular systems as well [64][65][66][67].
Although IFN-c is a strong inducer of helicases [8,9,38,39], we clearly show that OSM cooperated with IFN-c to enhance helicase expression in HDF. DDX58 and IFIH1 mRNA analysis as well as RIG-I and MDA-5 protein analysis revealed at least an additive effect in OSM/IFN-c-stimulated HDF. Furthermore, we observed a beneficial effect of OSM pre-incubation to sensitize double-stranded RNA and allow subsequent type I IFN production. As we did not observe a significant upregulation of TLR3 expression in response to OSM (not shown), we postulate that poly I:C which was added to the cells was recognized by RLR. Indeed, recent publications indicate that extracellular poly I:C is not solely recognized by TLR3 upon endocytosis, but by yet unknown mechanisms detected through MDA5 [68][69][70]. Of note, cytopathic assays carried out with encephalomyocarditis virus-infected HDF indicated that OSMinduced RLR expression was by itself insufficient to protect the cells from virus-mediated cell death (data not shown). Taken together, we demonstrate that OSM induces the expression of early antiviral genes in fibroblasts including IRF1/7/9 as well as the RNA helicases RIG-I and MDA5 and this allows a more rapid response to double-stranded RNA. Consequently, in cooperation with type II IFN, OSM appears to enhance the antiviral response. Thereby, our data extend recent findings which showed a cross-talk of OSM and IFNs in the protection from hepatitis C virus infection [19][20][21] by elucidating a novel, yet unaddressed mechanism of OSM-mediated immunomodulatory activities.